Turkey has observed a 84.72 million (26.6%) increase in the research & development by business enterprise, pharmaceutical industry in constant ppp $, which now stands at 402.99 million.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Turkey
No matching regions
Similar regions to Turkey
Business R&D pharmaceutical in constant PPP $
More indicators for Turkey
Government R&D in security as % of government support
8.37%
+1.22%
(2021)
Higher-education-finacing R&D financed by general university in local currency
296,259.07M
+138,306.86M
(2022)
R&D financed by rest of the world in local currency
26,425.12M
+10,976.51M
(2022)
Government R&D financed by rest of the world in local currency
1,253.35M
+691.97M
(2022)
Business R&D financed by rest of the world in local currency
17,924.29M
+7,818.67M
(2022)
Turkey Business R&D pharmaceutical in constant PPP $ between 2009 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 402.99M | +84.72M |
| 2020 | 318.27M | +48.29M |
| 2019 | 269.99M | -126.43M |
| 2018 | 396.42M | +140.15M |
| 2017 | 256.26M | -37.94M |
| 2016 | 294.20M | +78.64M |
| 2015 | 215.56M | +12.24M |
| 2014 | 203.32M | -6.20M |
| 2013 | 209.52M | +6.75M |
| 2012 | 202.77M | -18.15M |
| 2011 | 220.92M | +107.54M |
| 2010 | 113.39M | -7.45M |
| 2009 | 120.84M |